Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01151579 · ClinicalTrials.gov registry record · Phase 4
Effect of Nebulized Bronchodilators on Heart Rate
A Phase 4 study of Sepsis and COPD, sponsored by Fahim Khorfan, MD.
- Completed
- Registry status
- Phase 4
- Development phase
- 89
- Enrollment target
- 1
- Study location
NCT01151579 is a Phase 4 study of Sepsis and COPD that has completed, run by Fahim Khorfan, MD. The registered enrollment target is 89 participants, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01151579, a Phase 4 study of Sepsis and COPD, has completed, sponsored by Fahim Khorfan, MD.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 89 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.
Interventions
- DRUG Albuterol
- DRUG Levalbuterol
Study Locations (1)
Michigan
- Genesys Regional Medical Center - Grand Blanc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01151579
The ClinicalTrials.gov registry entry for NCT01151579 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,564-participant average among 90 other Sepsis trials with a reported enrollment target (99% lower). The listed sponsor is Fahim Khorfan, MD, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 2 interventions - of which Albuterol is the first listed.
NCT01151579 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01151579 about?
NCT01151579 is a clinical study titled "Effect of Nebulized Bronchodilators on Heart Rate". The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.
What is the current status of trial NCT01151579?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 89 participants. The study started on 2008-12. Estimated completion is 2009-11.
What conditions does trial NCT01151579 study?
This clinical trial studies the following conditions: Sepsis, COPD, Shock.
What interventions are being tested in trial NCT01151579?
The interventions under investigation include: Albuterol (DRUG), Levalbuterol (DRUG).
Who is sponsoring clinical trial NCT01151579?
This trial is sponsored by Fahim Khorfan, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01151579 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
RECRUITING · Phase 4
-
The PASTDUe Nutrition Ecosystem Project (PASTDUe)
ACTIVE NOT RECRUITING · Phase 4
-
The APS Phenotyping Study
RECRUITING
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.